Details of the Drug

General Information of Drug (ID: DMHNZ3U)

Drug Name
PRT543
Indication
Disease Entry ICD 11 Status REF
Hematologic tumour 2B33.Y Phase 1 [1]
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Drug Type
Small molecular drug
Cross-matching ID
PubChem CID
122497020
TTD ID
DC6UG5
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Protein arginine methyltransferase 5 (PRMT5) TTR1D7X ANM5_HUMAN Inhibitor [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT03886831) A Study of PRT543 in Participants With Advanced Solid Tumors and Hematologic Malignancies. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of Prelude Therapeutics.